Telix Pharmaceuticals’ March quarter performance beat forecasts with company management lauding the two product PSMA imaging strategy
Analysts’ assessments vary markedly on the impact on Pexa Group from potential regulatory reform
Guzman y Gomez silenced the naysayers with a more positive Australian sales update for the March quarter, sending shorters scrambling and brokers lifting forecasts
AI impacts on real estate assets are expected to be multi-functional, both positive efficiency/growth as well as disruptive depending on end user demand
Traditional documentation checking practices are becoming increasingly more unreliable, posits Digidentity’s MD Fred Slikker, so what’s the Finance industry’s response?
Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
Crude oil futures expiring in May represent potential shock for financial markets, DeCarleyTrading.com’s Carley Garner warns
Deep Yellow shares have found support at a key Fibonacci retracement level. Bullish RSI and MACD signals are fueling expectations of a move to new highs over the coming months
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
